Dr Mohamed Saad is a member of the Centre for Innate Immunity and Infectious Diseases.

Dr Mohamed Saad, Cancer and Immune Signalling Research group


Dr Mohamed Saad is an Honorary Research Associate at the Centre for Innate Immunity and Infectious Diseases (CiiiD), Department of Molecular and Translational Science (MTS), Faculty of Medicine, Nursing and Health Sciences (FMNHS), Monash University, Australia. Dr Saad completed his PhD studies in 2019 at Monash University, Australia, under the supervision of Professor Brendan Jenkins. Dr Saad has authored 31 publications and been awarded numerous highly-competitive scholarships, fellowships and awards, including Monash International Postgraduate Research Scholarship (MIPRS), Monash Publication Award, Hudson Postgraduate Travel Fellowship Award, Best Poster Prize at the Lorne Cancer conference, Milstein Travel Award from the International Cytokine and Interferon Society and Cancer Council Victoria (CCV) Postdoctoral Research Fellowship. Dr Saad was also selected as one of six Hudson Institute Emerging Leaders in 2021.

Dr Saad has presented his work at 14 national and international conferences and symposia, and has been invited to present his work at the University of Kiel, Germany (2019). Dr Saad is an active reviewer for many scientific journals including Oncogene, Molecular Therapy – Nucleic Acids, Molecular Cancer Research, Clinical and Translational Immunology, Cancers, Cytokine, Biomolecules and Cancer Medicine. Dr Saad also joined the editorial board of Frontiers in Oncology as a Review Editor in 2022. Dr Saad’s research interests include elucidating the roles of the ADAM17 protease, iRhom pseudoproteases and IL-6 cytokine signalling in dysregulated cell proliferation, inflammation and cell death.

Publication highlights